Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Dev Comp Immunol. 2018 Apr 9;85:125–133. doi: 10.1016/j.dci.2018.04.008

Table 3.

Impact of dsRNA injection on hazard ratios with and without fungal exposure

Treatment Oil-Only* Low* Medium* High*
dsGFP Uninjected 0.729 ± 0.599 1.018 ± 0.224 1.020 ± 0.177 0.873 ± 0.598
dsREL1 Uninjected 0.723 ± 0.244 1.061 ± 0.250 1.753 ± 0.167 2.848 ± 0.371
dsCactus Uninjected 1.733 ± 0.312 1.124 ± 0.405 1.010 ± 0.346 1.349 ± 0.497
dsREL1 dsGFP 0.911 ± 0.461 1.361 ± 0.208 1.745 ± 0.291 2.641 ± 0.602
dsCactus dsGFP 2.131 ± 1.187 1.071 ± 0.140 1.217 ± 0.302 1.325 ± 0.237
dsREL1 dsCactus 2.147 ± 0.705 0.784 ± 0.227 0.586 ± 0.049 0.386 ± 0.046
*

median ± ½ range